文献速递脊柱关节炎

中轴型脊柱关节炎诊断延迟普遍存在:来自英国国家早期炎性关节炎审计的结果

Diagnostic delay is common for patients with axial spondyloarthritis: results from the National Early Inflammatory Arthritis Audit.
PubMed 文献 · Rheumatology (Oxford) · 2022-01-01

基于英国国家早期炎性关节炎审计(NEIAA)2018年5月至2020年3月招募的784例中轴型脊柱关节炎(axSpA)患者,并与9270例类风湿关节炎(RA)和370例机械性背痛(MBP)患者比较。axSpA患者首次风湿科评估前症状持续时间长于RA(P<0.001),79.7%的axSpA患者症状持续超过6个月;转诊后至首次风湿科评估的中位时间axSpA长于RA(36天 vs 24天;P<0.001),与MBP相似(39天;P=0.30)。符合早期炎性关节炎路径随访条件的axSpA患者中接受疾病教育的比例低于RA(77.5% vs 97.8%)。

要点

  • axSpA患者首次风湿科评估前症状持续时间常超过6个月(79.7%),诊断延迟显著。
  • 转诊后至首次风湿科评估的中位时间axSpA为36天,长于RA的24天(P<0.001)。
  • axSpA患者接受疾病教育的比例低于RA患者(77.5% vs 97.8%)。

核心结论

  • 尽管疾病认识和转诊指南已更新,axSpA的诊断延迟仍是主要挑战。
  • axSpA患者接受疾病教育的比例低于RA患者,凸显专科门诊和支持项目的需求。

研究设计与样本

  • 基于英国国家早期炎性关节炎审计(NEIAA)2018年5月至2020年3月招募的新转诊患者进行分析。
  • axSpA患者784例,对照为同期RA患者9270例和机械性背痛(MBP)患者370例。
  • 分析社会人口学和临床指标,包括转诊和评估时间。

主要发现

  • axSpA患者首次风湿科评估前症状持续时间长于RA患者(P<0.001),与MBP患者差异无统计学意义(P=0.062)。
  • 79.7%的axSpA患者症状持续时间超过6个月,RA患者为33.7%,MBP患者为76.0%。
  • 转诊后至首次风湿科评估的中位时间axSpA为36天,长于RA的24天(P<0.001),与MBP的39天相似(P=0.30)。
  • 符合早期炎性关节炎路径随访条件的axSpA患者中,接受疾病教育的比例为77.5%,低于RA患者的97.8%。
  • RA患者报告对自身疾病和治疗的理解更好。

关键数值与推荐

  • axSpA患者症状持续时间超过6个月的比例为79.7%。
  • axSpA患者转诊后至首次风湿科评估的中位时间为36天,RA为24天,MBP为39天。
  • axSpA患者接受疾病教育的比例为77.5%,RA患者为97.8%。

临床怎么用

  • 风湿免疫科医生应关注axSpA患者转诊前的长症状持续时间,提高对axSpA的早期识别。
  • 针对axSpA患者加强疾病教育,弥补与RA患者之间的教育差距。
  • 考虑建立axSpA专科门诊和支持项目以改善诊断延迟和患者教育。

局限性

  • 原文未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Updated guidelines for patients with axial SpA (axSpA) have sought to reduce diagnostic delay by raising awareness among clinicians. We used the National Early Inflammatory Arthritis Audit (NEIAA) to describe baseline characteristics and time to diagnosis for newly referred patients with axSpA in England and Wales. METHODS: Analyses were performed on sociodemographic and clinical metrics, including time to referral and assessment, for axSpA patients (n = 784) recruited to the NEIAA between May 2018 and March 2020. Comparators were patients recruited to the NEIAA with RA (n = 9270) or mechanical back pain (MBP; n = 370) in the same period. RESULTS: Symptom duration prior to initial rheumatology assessment was longer in axSpA than RA patients (P < 0.001) and non-significantly longer in axSpA than MBP patients (P = 0.062): 79.7% of axSpA patients had symptom durations of >6 months, compared with 33.7% of RA patients and 76.0% of MBP patients. Following referral, the median time to initial rheumatology assessment was longer for axSpA than RA patients (36 vs 24 days; P < 0.001) and similar to MBP patients (39 days; P = 0.30). Of the subset of patients deemed eligible for early inflammatory arthritis pathway follow-up, fewer axSpA than RA patients had disease education provided (77.5% vs 97.8%) and RA patients reported a better understanding of their condition and treatment. CONCLUSION: Diagnostic delay in axSpA remains a major challenge despite improved disease understanding and updated referral guidelines. Disease education is provided to fewer axSpA than RA patients, highlighting the need for specialist clinics and support programmes for axSpA patients.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Russell MD, Coath F, Yates M, et al. Diagnostic delay is common for patients with axial spondyloarthritis: results from the National Early Inflammatory Arthritis Audit. Rheumatology (Oxford). 2022. PMID: 33982063. doi:10.1093/rheumatology/keab428

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。